N
ZYME icon

Nuveen’s Zymeworks ZYME Stock Holding History

Nuveen’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.3M Buy
651,662
+3,336
+0.5% +$78.9K ﹤0.01% 1252
2025
Q4 		$17.1M Buy
648,326
+82,941
+15% +$1.81M ﹤0.01% 1233
2025
Q3 		$9.66M Sell
565,385
-89,531
-14% -$1.28M ﹤0.01% 1577
2025
Q2 		$8.22M Buy
654,916
+456,104
+229% +$5.43M ﹤0.01% 1630
2025
Q1 		$2.37M Sell
198,812
-8,211
-4% -$112K ﹤0.01% 2267
2024
Q4 		$3.03M Buy
207,023
+886
+0.4% +$12.4K ﹤0.01% 2215
2024
Q3 		$2.59M Buy
206,137
+527
+0.3% +$5.74K ﹤0.01% 2295
2024
Q2 		$1.75M Buy
205,610
+2,094
+1% +$18.6K ﹤0.01% 2451
2024
Q1 		$2.14M Buy
203,516
+8,534
+4% +$94.8K ﹤0.01% 2370
2023
Q4 		$2.03M Sell
194,982
-835
-0.4% -$6.66K ﹤0.01% 2407
2023
Q3 		$1.24M Sell
195,817
-45,983
-19% -$340K ﹤0.01% 2484
2023
Q2 		$2.09M Buy
+241,800
New +$2.16M ﹤0.01% 2326
2022
Q2 		– Sell
-36,322
Closed -$254K – 3513
2022
Q1 		$254K Buy
36,322
+3,008
+9% +$26.8K ﹤0.01% 3148
2021
Q4 		$546K Buy
+33,314
New +$695K ﹤0.01% 3055
2021
Q3 		– Sell
-70,351
Closed -$2.44M – 3453
2021
Q2 		$2.44M Buy
+70,351
New +$2.23M ﹤0.01% 2609
2021
Q1 		– Sell
-21,576
Closed -$1.02M – 3408
2020
Q4 		$1.02M Buy
21,576
+5,156
+31% +$239K ﹤0.01% 2798
2020
Q3 		$765K Sell
16,420
-28,706
-64% -$986K ﹤0.01% 2800
2020
Q2 		$1.63M Sell
45,126
-38,165
-46% -$1.41M ﹤0.01% 2425
2020
Q1 		$2.95M Buy
+83,291
New +$3.41M ﹤0.01% 1997

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Nuveen's ZYME Position: Q1 2026 in Review

Nuveen increased its Zymeworks (ZYME) stake by 0.51% in Q1 2026, buying an estimated $78.9K and bringing the position to 651,662 shares worth $16.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1252.

Nuveen first reported a position in ZYME in Q1 2020 and has held it in 19 quarters since. The position peaked at $17.1M in Q4 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Nuveen held 651,662 shares of Zymeworks worth $16.3M as of Q1 2026.
  • Nuveen bought 3,336 Zymeworks shares in Q1 2026, an estimated $78.9K.
  • Zymeworks made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #1252 holding.
  • Nuveen first reported a position in Zymeworks in Q1 2020 and has held it in 19 quarters since.
  • Nuveen's Zymeworks position peaked at $17.1M in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.